| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +0.00% | +7.83% | -0.28% | +8.10% | +6.82% | — |
| 14d | 4 | +0.00% | +7.87% | +1.18% | +6.69% | +8.42% | — |
| 30d | 4 | +0.00% | +15.70% | +4.21% | +11.49% | +9.53% | — |
| 60d | 4 | +0.00% | +11.69% | +7.70% | +3.99% | +2.85% | — |
| 90d | 4 | +25.00% | +9.98% | +10.47% | -0.49% | +1.23% | — |
| 180d | 4 | +75.00% | -2.21% | +19.13% | -21.33% | -22.06% | — |
| 1y | 4 | +100.00% | -24.17% | +36.25% | -60.42% | -55.50% | — |
| 2y | 4 | +100.00% | -81.47% | +23.51% | -104.99% | -100.30% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 50,000 | — | — | 155,000 | Dec 11, 2020 | Dec 11, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 50,000 | $56.13 | $2.81M | 0 | Dec 11, 2020 | Dec 11, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, External Affairs | 50,000 | $6.55 | $327.5K | 50,000 | Dec 11, 2020 | Dec 11, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 25,000 | — | — | 55,000 | Sep 15, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, External Affairs | 25,000 | $6.32 | $158.0K | 25,000 | Sep 15, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 25,000 | $44.00 | $1.10M | 0 | Sep 15, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 25,000 | — | — | 205,000 | Sep 14, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, External Affairs | 25,000 | $6.55 | $163.8K | 25,000 | Sep 14, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, External Affairs | 25,000 | $42.50 | $1.06M | 0 | Sep 14, 2020 | Sep 16, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Clinical Diagnostics | 20,000 | — | — | 230,000 | May 15, 2020 | May 18, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, Clinical Diagnostics | 20,000 | $6.32 | $126.4K | 20,000 | May 15, 2020 | May 18, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Clinical Diagnostics | 40,000 | $38.01 | $1.52M | 0 | May 15, 2020 | May 18, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | SALE SVP, Clinical Diagnostics | 20,000 | — | — | 80,000 | May 15, 2020 | May 18, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASE SVP, Clinical Diagnostics | 20,000 | $6.55 | $131.0K | 40,000 | May 15, 2020 | May 18, 2020 ↗ |
| ADPT ADAPTIVE BIOTECHNOLOGIES CORP | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Feb 13, 2020 | Feb 18, 2020 ↗ |